Tralokinumab monotherapy for adolescent subjects with moderate-to-severe atopic dermatitis ECZTRA 6 (ECZema TRAlokinumab trial no. 6)

Project: Research project

Project Details

StatusActive
Effective start/end date2/11/1912/31/50

Funding

  • Northwestern University
  • Leo Pharma, Inc.